CRELD1 Antikörper
-
- Target Alle CRELD1 Antikörper anzeigen
- CRELD1 (Cysteine-Rich with EGF-Like Domains 1 (CRELD1))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CRELD1 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (IHC), Western Blotting (WB), ELISA
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Synthetic peptide of human CRELD1
- Isotyp
- IgG
- Top Product
- Discover our top product CRELD1 Primärantikörper
-
-
- Applikationshinweise
- WB 1:500-1:2000, IHC 1:50-1:200
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.8 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- CRELD1 (Cysteine-Rich with EGF-Like Domains 1 (CRELD1))
- Andere Bezeichnung
- CRELD1 (CRELD1 Produkte)
- Synonyme
- AVSD2 antikoerper, CIRRIN antikoerper, AI843811 antikoerper, cysteine rich with EGF like domains 1 antikoerper, cysteine-rich with EGF-like domains 1 antikoerper, CRELD1 antikoerper, Creld1 antikoerper
- Hintergrund
- This gene encodes a member of a subfamily of epidermal growth factor-related proteins. The encoded protein is characterized by a cysteine-rich with epidermal growth factor-like domain. This protein may function as a cell adhesion molecule. Mutations in this gene are the cause of atrioventricular septal defect. Alternate splicing results in multiple transcript variants.
- Molekulargewicht
- 45 kDa
- NCBI Accession
- NP_001026887
- UniProt
- Q96HD1
-